{"id":5072,"date":"2025-03-27T16:46:22","date_gmt":"2025-03-27T15:46:22","guid":{"rendered":"https:\/\/www.genexpath.com\/?page_id=5072"},"modified":"2025-03-28T15:15:50","modified_gmt":"2025-03-28T14:15:50","slug":"sarcomafusion","status":"publish","type":"page","link":"https:\/\/old.genexpath.com\/en\/nos-produits\/sarcomafusion\/","title":{"rendered":"SarcomaFusion test"},"content":{"rendered":"
<\/span>\"Banni\u00e8re
\n
\n
\n

SarcomaFusion test<\/strong><\/h1>\n\n\n\n

Detection of fusion transcripts identified in sarcomas<\/h2>\n<\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n
\n
\n
Home<\/a><\/span> \u00bb Our products<\/a><\/span> \u00bb SarcomaFusion test<\/span><\/span><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n
\n
\n

Fusion transcripts are found in approximately 1\/3 of soft tissue tumors and to date, the literature has described more than 140 fusions. They are often associated with a particular histological subtype and, consequently, with specific treatments. Thus, they constitute ideal molecular diagnostic markers.<\/p>\n\n\n\n

The detection of these fusion transcripts is therefore essential for patient management.<\/p>\n\n\n\n

The SarcomaFusion test<\/strong> test allows the detection of fusion transcripts identified in sarcomas in a single test.<\/p>\n\n\n\n

This test is CE-IVD marked for diagnostic use in Vitro test<\/em>, guaranteeing its compliance with European safety and performance requirements.<\/p>\n\n\n\n

Here are some examples of detectable fusion transcripts associated with their pathology and possible treatments:<\/p>\n\n\n\n

\n
\n

<\/p>\n\n\n\n